26-Amino-10,19-dioxo-3,6,12,15,21,24-hexaoxa-9,18-diazahexacosanoic acid

Catalog No.: 
ACTHVS433
CAS No.: 
2773558-06-6
Molecular Formula: 
C18H35N3O10
Molecular Weight: 
453.49
26-Amino-10,19-dioxo-3,6,12,15,21,24-hexaoxa-9,18-diazahexacosanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$105.00In stockInquiry
100mg95%$168.00In stockInquiry
250mg95%$350.00In stockInquiry
1g95%$934.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name26-Amino-10,19-dioxo-3,6,12,15,21,24-hexaoxa-9,18-diazahexacosanoic acid
IUPAC Name26-amino-10,19-dioxo-3,6,12,15,21,24-hexaoxa-9,18-diazahexacosanoic acid
MDL No.MFCD18427347
Molecular FormulaC18H35N3O10
Molecular Weight453.49
SMILESO=C(O)COCCOCCNC(COCCOCCNC(COCCOCCN)=O)=O
InChI KeyDLDHTLVGQUKJDC-UHFFFAOYSA-N
Synonym3AEEA;Semaglutide impurity 57;Semaglutide Impurity 113
CAS No.2773558-06-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTHVS433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHVS433 route product structure diagram
    ACTHVS4332773558-06-6In Stock
Inquiry

2. ACTHVS433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHVS433 route product structure diagram
    ACTHVS4332773558-06-6In Stock
Inquiry

3. ACTHVS433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTHVS433 route product structure diagram
    ACTHVS4332773558-06-6In Stock
Inquiry

Comments (0)